Valerie C. Nemov , Alden Dunham , Claudio Schenone Giugni , Viviana De Assis , Emily Coughlin , Mary Ashley Cain , Judette M. Louis , Daniela R. Crousillat
{"title":"心血管疾病妇女的心血管危险因素负担和不良妊娠结局","authors":"Valerie C. Nemov , Alden Dunham , Claudio Schenone Giugni , Viviana De Assis , Emily Coughlin , Mary Ashley Cain , Judette M. Louis , Daniela R. Crousillat","doi":"10.1016/j.ahjo.2025.100611","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>We investigated associations between pre-conception cardiovascular risk factor burden and adverse pregnancy outcomes (APOs) in women with cardiovascular disease (CVD).</div></div><div><h3>Methods</h3><div>We created a patient registry from our cardio-obstetrics program. APOs were defined as intrauterine growth restriction (IUGR), hypertensive disorder of pregnancy (HDP), and pre-term birth.</div></div><div><h3>Results</h3><div>Analysis included 63 women. 42 (66.7 %) experienced no APOs, while 21 (33.3 %) did; 18 (28.6 %), 3 (4.8 %), and 12 (19.0 %) developed an HDP, IUGR, or delivered pre-term, respectively. Pre-conception risk burden was not a significant predictor of APO development (<em>p</em> <em>=</em> 0.139). However, patients with pre-term delivery had a significantly higher number of risk factors (<em>p</em> < 0.001), as did patients with chronic hypertension with superimposed HDP (<em>p</em> < 0.001).</div></div><div><h3>Discussion</h3><div>Women delivering pre-term have higher risk factor burdens. Since pre-term birth is associated with future CVD in women independent of cause, optimization of preconception cardiovascular health could help mitigate these risks in an already vulnerable population.</div></div>","PeriodicalId":72158,"journal":{"name":"American heart journal plus : cardiology research and practice","volume":"59 ","pages":"Article 100611"},"PeriodicalIF":1.8000,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cardiovascular risk factor burden and adverse pregnancy outcomes in women with cardiovascular disease\",\"authors\":\"Valerie C. Nemov , Alden Dunham , Claudio Schenone Giugni , Viviana De Assis , Emily Coughlin , Mary Ashley Cain , Judette M. Louis , Daniela R. Crousillat\",\"doi\":\"10.1016/j.ahjo.2025.100611\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>We investigated associations between pre-conception cardiovascular risk factor burden and adverse pregnancy outcomes (APOs) in women with cardiovascular disease (CVD).</div></div><div><h3>Methods</h3><div>We created a patient registry from our cardio-obstetrics program. APOs were defined as intrauterine growth restriction (IUGR), hypertensive disorder of pregnancy (HDP), and pre-term birth.</div></div><div><h3>Results</h3><div>Analysis included 63 women. 42 (66.7 %) experienced no APOs, while 21 (33.3 %) did; 18 (28.6 %), 3 (4.8 %), and 12 (19.0 %) developed an HDP, IUGR, or delivered pre-term, respectively. Pre-conception risk burden was not a significant predictor of APO development (<em>p</em> <em>=</em> 0.139). However, patients with pre-term delivery had a significantly higher number of risk factors (<em>p</em> < 0.001), as did patients with chronic hypertension with superimposed HDP (<em>p</em> < 0.001).</div></div><div><h3>Discussion</h3><div>Women delivering pre-term have higher risk factor burdens. Since pre-term birth is associated with future CVD in women independent of cause, optimization of preconception cardiovascular health could help mitigate these risks in an already vulnerable population.</div></div>\",\"PeriodicalId\":72158,\"journal\":{\"name\":\"American heart journal plus : cardiology research and practice\",\"volume\":\"59 \",\"pages\":\"Article 100611\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-09-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American heart journal plus : cardiology research and practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2666602225001144\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American heart journal plus : cardiology research and practice","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666602225001144","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Cardiovascular risk factor burden and adverse pregnancy outcomes in women with cardiovascular disease
Introduction
We investigated associations between pre-conception cardiovascular risk factor burden and adverse pregnancy outcomes (APOs) in women with cardiovascular disease (CVD).
Methods
We created a patient registry from our cardio-obstetrics program. APOs were defined as intrauterine growth restriction (IUGR), hypertensive disorder of pregnancy (HDP), and pre-term birth.
Results
Analysis included 63 women. 42 (66.7 %) experienced no APOs, while 21 (33.3 %) did; 18 (28.6 %), 3 (4.8 %), and 12 (19.0 %) developed an HDP, IUGR, or delivered pre-term, respectively. Pre-conception risk burden was not a significant predictor of APO development (p= 0.139). However, patients with pre-term delivery had a significantly higher number of risk factors (p < 0.001), as did patients with chronic hypertension with superimposed HDP (p < 0.001).
Discussion
Women delivering pre-term have higher risk factor burdens. Since pre-term birth is associated with future CVD in women independent of cause, optimization of preconception cardiovascular health could help mitigate these risks in an already vulnerable population.